Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 143.62

-0.9%

Nov 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (793)	8/28/2001 10:41:07 PM
From: Scott H. Davis	Read Replies (1) of 1834

The good news is that NBIX is in good position with good news - clinical, financial and analyst stuff (I know we largely blow off, but they influence some.) The downside is that NBIX is in an overbought state again - not seriously, but materially. And it's headed up against several resistance points technically while technically somewhat extended. Bottom line is without a major improvement in the market, or more strong news, I don't see much upside near term. I also don't expect much contraction apart from some bad market downside moves, or bad clinical news. IMSCO Scott siliconinvestor.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next